Pronoran may be available in the countries listed below.
Piribedil is reported as an ingredient of Pronoran in the following countries:
International Drug Name Search
Codethyline may be available in the countries listed below.
Ethylmorphine hydrochloride (a derivative of Ethylmorphine) is reported as an ingredient of Codethyline in the following countries:
International Drug Name Search
Sertralin Krka may be available in the countries listed below.
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralin Krka in the following countries:
International Drug Name Search
In the US, Chlordiazepoxide (chlordiazepoxide systemic) is a member of the drug class benzodiazepines and is used to treat Alcohol Withdrawal, Anxiety, Burning Mouth Syndrome and Light Sedation.
US matches:
Rec.INN
N05BA02
0000058-25-3
C16-H14-Cl-N3-O
299
Anxiolytic agent
Benzodiazepine derivative
Agent for premedication
Muscle relaxant
Treatment of alcohol withdrawal symptoms
3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Xylocaine Injection may be available in the countries listed below.
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xylocaine Injection in the following countries:
International Drug Name Search
Rec.INN
0078113-36-7
C43-H78-N6-O13
887
Immunomodulator
2-Acetamido-3-O-[(R)-1-[[(S)-1-[[(R)-1-carbamoyl-3-[[(S)-carboxy-5-stearamidopentyl]carbamoyl] propyl]carbamoyl]ethyl]carbamoyl]ethyl]-2-deoxy-D-glucopyranose
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Pravastatin Pliva may be available in the countries listed below.
Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatin Pliva in the following countries:
International Drug Name Search
Fusidate may be available in the countries listed below.
Fusidic Acid sodium (a derivative of Fusidic Acid) is reported as an ingredient of Fusidate in the following countries:
International Drug Name Search
Oftimolo may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Oftimolo in the following countries:
International Drug Name Search
Dermiplus-V may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Dermiplus-V in the following countries:
International Drug Name Search
Clamist may be available in the countries listed below.
Clemastine fumarate (a derivative of Clemastine) is reported as an ingredient of Clamist in the following countries:
International Drug Name Search
Zolpidem Normon may be available in the countries listed below.
Zolpidem is reported as an ingredient of Zolpidem Normon in the following countries:
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem Normon in the following countries:
International Drug Name Search
Generic Name: dantrolene (oral) (DAN troe leen)
Brand Names: Dantrium
Dantrolene is a muscle relaxant.
Dantrolene is used to treat muscle spasticity (stiffness and spasms) caused by conditions such as a spinal cord injury, stroke, cerebral palsy, or multiple sclerosis.
Dantrolene is also used to prevent muscle stiffness and spasms caused by malignant hyperthermia (a rapid rise in body temperature) that can occur during surgery with certain types of anesthesia.
Dantrolene may also be used for other purposes not listed in this medication guide.
Before taking dantrolene, tell your doctor if you have a history of liver disease, a breathing disorder such as COPD, heart disease, or a history of heart attack.
Your doctor may occasionally change your dose to make sure you get the best results from this medication.
If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:
a history of liver disease;
a breathing disorder such as COPD (chronic obstructive pulmonary disease); or
heart disease, or a history of heart attack.
Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.
Your doctor may occasionally change your dose to make sure you get the best results from this medication.
See also: Dantrium dosage (in more detail)
Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include vomiting, diarrhea, and extreme drowsiness or muscle weakness.
severe diarrhea or constipation;
weak or shallow breathing;
pale skin, easy bruising or bleeding;
trouble swallowing, especially if it causes choking;
nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
black, bloody, or tarry stools;
coughing up blood or vomit that looks like coffee grounds;
seizure (black-out or convulsions); or
urinating less than usual or not at all.
Less serious side effects may include:
drowsiness, dizziness, weakness, tired feeling;
mild diarrhea or constipation;
mild nausea, vomiting, stomach pain;
problems with speech, balance, or walking;
headache, confusion, vision problems;
sleep problems (insomnia);
sweating, drooling; or
urinating more than usual.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medications you use, especially:
birth control pills and other hormones; or
a heart or blood pressure medication such as amlodipine (Norvasc), diltiazem (Tiazac, Cartia, Cardizem), felodipine (Plendil), nicardipine (Cardene), nifedipine (Procardia, Adalat), nimodipine (Nimotop), nisoldipine (Sular), or verapamil (Calan, Covera, Isoptin, Verelan).
This list is not complete and there may be other drugs that can interact with dantrolene. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: Dantrium side effects (in more detail)
Dexalgen may be available in the countries listed below.
Hydroxocobalamin is reported as an ingredient of Dexalgen in the following countries:
International Drug Name Search
Tetraguard may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Oxytetracycline magnesiumoxyethylammonium (a derivative of Oxytetracycline) is reported as an ingredient of Tetraguard in the following countries:
International Drug Name Search
Risperidona Asol may be available in the countries listed below.
Risperidone is reported as an ingredient of Risperidona Asol in the following countries:
International Drug Name Search
Generic Name: rivastigmine transdermal (riv a STIG meen)
Brand Names: Exelon
Rivastigmine improves the function of nerve cells in the brain. It works by preventing the breakdown of a chemical called acetylcholine (ah see til KO leen). People with dementia usually have lower levels of this chemical, which is important for the processes of memory, thinking, and reasoning.
Rivastigmine transdermal (skin patch) is used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease.
Rivastigmine transdermal may also be used for purposes not listed in this medication guide.
Before using rivastigmine transdermal, tell your doctor if you have liver disease, a heart rhythm disorder such as "sick sinus syndrome" (slow heartbeats), an enlarged prostate, urination problems, a seizure disorder, asthma or allergies, tremors or uncontrolled muscle movements, or a history of stomach ulcer.
If you stop using rivastigmine transdermal for any reason, do not restart the medication without talking to your doctor first. You may need to restart treatment with a lower dose.
If you need surgery, tell the surgeon ahead of time that you are using rivastigmine transdermal.
To make sure you can safely use rivastigmine transdermal, tell your doctor if you have any of these other conditions:
liver disease;
recent weight loss or lack of appetite;
a heart rhythm disorder such as "sick sinus syndrome" (slow heartbeats);
a history of stomach ulcer;
an enlarged prostate or urination problems;
epilepsy or other seizure disorder;
asthma or any allergies; or
tremors (dyskinesia) or uncontrolled muscle movements.
Use exactly as prescribed by your doctor. Do not apply more patches or use them for longer than recommended. Follow the directions on your prescription label.
This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
Apply the skin patch to a flat, hairless area of the chest, back, side, or outer side of your upper arm. Press the patch firmly with the palm making sure it sticks firmly, especially around the edges.
Avoid placing the patch where it will be rubbed by tight clothing, or in the folds of your skin. The patch should remain flat on the skin at all times. Take care to avoid accidentally removing the patch while showering or during physical activity.
You will wear the patch for 24 hours and then remove it and put on a new one. Apply the new patch to a different skin area on your back each day. Do not use the same spot again for at least 14 days.
If a patch falls off, apply a new patch and wear it for the rest of the day. Change the patch at your usual time the next day.
After removing a skin patch fold it in half, sticky side in, and throw it away where children and pets cannot get to it.
If you need surgery, tell the surgeon ahead of time that you are using rivastigmine transdermal. You may need to stop using the medicine for a short time.
It may take up to 4 weeks of using this medicine before your symptoms improve. For best results, keep using the patches as directed.
If you stop using rivastigmine transdermal for any reason, do not restart the medication without talking to your doctor first. You may need to restart treatment with a lower dose.
Apply a skin patch as soon as you remember. Or you may wait until the next day to apply a patch and skip the missed dose. Do not use extra patches to make up the missed dose.
Overdose symptoms may include severe nausea, vomiting, diarrhea, slow heartbeat, slow or shallow breathing, or hallucinations.
Do not use any cream, lotion, ointment, oil, or powder on the skin where you plan to apply a skin patch. The patch may not stick well to the skin.
nausea and vomiting, loss of appetite, weight loss;
black or bloody stools, coughing up blood or vomit that looks like blood or coffee grounds;
restless muscle movements in your eyes, tongue, jaw, or neck, tremor (uncontrolled shaking);
sudden numbness or weakness, headache, confusion, problems with vision, speech, or balance;
pale skin, easy bruising or bleeding;
confusion, hallucinations; or
pain or burning when you urinate.
Less serious side effects may include:
diarrhea, stomach pain;
headache, tired feeling;
anxiety, depressed mood;
redness, itching, or swelling where the patch was worn;
dizziness, spinning feeling; or
sleep problems (insomnia).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Alzheimer's Disease:
Initial Oral Dose: 1.5 mg orally twice a day with morning and evening meals.
After a minimum of two weeks of treatment, if the initial dosage is well tolerated, it may be increased to 3 mg twice a day. Subsequent increases to 4.5 mg and 6 mg twice a day should be attempted only after a minimum of 2 weeks at the previous dosage. The dosage of rivastigmine shown to be effective in controlled clinical trials is 3 to 6 mg twice a day. There is evidence from the clinical trials that dosages at the higher end of this range may be more beneficial.
Initial Patch Dose: 4.6 mg/24 hours
After a minimum of four weeks of treatment and if well tolerated, the dose of the patch be increased to 9.5 mg/24 hours, which is the recommended effective dose.
Maintenance Patch Dose: Dose increases should occur only after a minimum of four weeks at the previous dose, and only if the previous dose has been well tolerated. The maximum recommended dose is 9.5 mg/ 24 hours. Higher doses confer no appreciable additional benefit, and are associated with significant increase in the incidence of adverse events.
Switching from Capsules or Oral Solution: Patients treated with capsules or oral solution may be switched to patches as follows:
A patient who is on a total daily dose of less than 6 mg of oral rivastigmine can be switched to patch dose of 4.6 mg/24 hours.
A patient who is on a total daily dose of 6 to 12 mg of oral rivastigmine may be directly switched to a patch dose of 9.5 mg/24 hours.
It is recommended to apply the first patch on the day following the last oral dose.
Usual Adult Dose for Parkinson's Disease:
Initial dose: 1.5 mg orally twice a day with morning and evening meals
Subsequently, the dose may be increased to 3 mg orally twice a day and further to 4.5 mg twice a day and 6 mg twice a day (based on tolerability) with a minimum of 4 weeks at each dose.
Initial Patch Dose: 4.6 mg/24 hours
After a minimum of four weeks of treatment and if well tolerated, the dose of the patch be increased to 9.5 mg/24 hours, which is the recommended effective dose.
Maintenance Patch Dose: Dose increases should occur only after a minimum of four weeks at the previous dose, and only if the previous dose has been well tolerated. The maximum recommended dose is 9.5 mg/ 24 hours. Higher doses confer no appreciable additional benefit, and are associated with significant increase in the incidence of adverse events.
Switching from Capsules or Oral Solution: Patients treated with capsules or oral solution may be switched to patches as follows:
A patient who is on a total daily dose of less than 6 mg of oral rivastigmine can be switched to patch dose of 4.6 mg/24 hours.
A patient who is on a total daily dose of 6 to 12 mg of oral rivastigmine may be directly switched to a patch dose of 9.5 mg/24 hours.
It is recommended to apply the first patch on the day following the last oral dose.
The following drugs can interact with rivastigmine transdermal. Tell your doctor if you are using any of these:
atropine (Donnatal, and others), benztropine (Cogentin), dimenhydrinate (Dramamine), methscopolamine (Pamine), or scopolamine (Transderm-Scop);
bronchodilators such as ipratroprium (Atrovent) or tiotropium (Spiriva);
glycopyrrolate (Robinul);
mepenzolate (Cantil);
bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), or solifenacin (Vesicare);
irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Anaspaz, Cystospaz, Levsin, and others), or propantheline (Pro-Banthine);
aspirin or other NSAIDs (non-steroidal anti-inflammatory drugs) such as ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn, Naprelan, Treximet), celecoxib (Celebrex), diclofenac (Cataflam, Voltaren), indomethacin (Indocin), meloxicam (Mobic), and others; or
medicines used to treat Parkinson's Disease such as levodopa (Dopar, Larodopa, Sinemet, Atamet, others), bromocriptine (Parlodel, others), pergolide (Permax), pramipexole (Mirapex), or ropinirole (Requip).
This list is not complete and other drugs may interact with rivastigmine transdermal. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: rivastigmine side effects (in more detail)
Crezyme may be available in the countries listed below.
Pancreatin is reported as an ingredient of Crezyme in the following countries:
International Drug Name Search
USAN
0000097-59-6
C4-H6-N4-O3
158
Wound healing agent
Dermatological agent: Antipsoriatic
Urea, (2,5-dioxo-4-imidazolidinyl)-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| USAN | United States Adopted Name |
Cisplatine Merck may be available in the countries listed below.
Cisplatin is reported as an ingredient of Cisplatine Merck in the following countries:
International Drug Name Search
Propiverin-HCl Stada may be available in the countries listed below.
Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Propiverin-HCl Stada in the following countries:
International Drug Name Search
Prolift may be available in the countries listed below.
Reboxetine is reported as an ingredient of Prolift in the following countries:
Reboxetine mesilate (a derivative of Reboxetine) is reported as an ingredient of Prolift in the following countries:
International Drug Name Search
Roaccutane may be available in the countries listed below.
UK matches:
Isotretinoin is reported as an ingredient of Roaccutane in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Shemol may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Shemol in the following countries:
International Drug Name Search
Asamax may be available in the countries listed below.
Mesalazine is reported as an ingredient of Asamax in the following countries:
International Drug Name Search
By-Madol may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of By-Madol in the following countries:
International Drug Name Search
In the US, Cancidas (caspofungin systemic) is a member of the drug class echinocandins and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic, Esophageal Candidiasis and Febrile Neutropenia.
US matches:
UK matches:
Caspofungin is reported as an ingredient of Cancidas in the following countries:
Caspofungin diacetate (a derivative of Caspofungin) is reported as an ingredient of Cancidas in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Gliprex may be available in the countries listed below.
Glimepiride is reported as an ingredient of Gliprex in the following countries:
International Drug Name Search
Corectin may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Corectin in the following countries:
International Drug Name Search
Calcio Levofolinato Fidia may be available in the countries listed below.
Calcium Levofolinate pentahydrate (a derivative of Calcium Levofolinate) is reported as an ingredient of Calcio Levofolinato Fidia in the following countries:
International Drug Name Search
Norlopin may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Norlopin in the following countries:
International Drug Name Search
In the US, Campral (acamprosate systemic) is a member of the drug class drugs used in alcohol dependence and is used to treat Alcohol Dependence.
US matches:
UK matches:
Acamprosate is reported as an ingredient of Campral in the following countries:
Acamprosate calcium salt (a derivative of Acamprosate) is reported as an ingredient of Campral in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Onetrim may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Onetrim in the following countries:
Trimethoprim is reported as an ingredient of Onetrim in the following countries:
International Drug Name Search
Guaphan may be available in the countries listed below.
Guaifenesin is reported as an ingredient of Guaphan in the following countries:
International Drug Name Search
Raniprotect may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Raniprotect in the following countries:
International Drug Name Search
Zipéprol may be available in the countries listed below.
Zipéprol (DCF) is also known as Zipeprol (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Premosan may be available in the countries listed below.
Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Premosan in the following countries:
International Drug Name Search
Finasterida Pharmakern may be available in the countries listed below.
Finasteride is reported as an ingredient of Finasterida Pharmakern in the following countries:
International Drug Name Search
Calicumborogluconat may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Calcium Gluconate is reported as an ingredient of Calicumborogluconat in the following countries:
International Drug Name Search
Cefuroxime axetil Ranbaxy may be available in the countries listed below.
Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Cefuroxime axetil Ranbaxy in the following countries:
International Drug Name Search
Lotronex is a brand name of alosetron, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Lotronex available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lotronex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Codipront may be available in the countries listed below.
Codeine is reported as an ingredient of Codipront in the following countries:
Phenyltoloxamine is reported as an ingredient of Codipront in the following countries:
International Drug Name Search
Tial may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tial in the following countries:
International Drug Name Search
Scripto-metic may be available in the countries listed below.
Prochlorperazine maleate (a derivative of Prochlorperazine) is reported as an ingredient of Scripto-metic in the following countries:
International Drug Name Search
Esopraz may be available in the countries listed below.
Omeprazole is reported as an ingredient of Esopraz in the following countries:
Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Esopraz in the following countries:
International Drug Name Search
Ikestatina may be available in the countries listed below.
Somatostatin x acetate (a derivative of Somatostatin) is reported as an ingredient of Ikestatina in the following countries:
International Drug Name Search
Antiseptin may be available in the countries listed below.
Triclosan is reported as an ingredient of Antiseptin in the following countries:
International Drug Name Search
doo-TAS-ter-ide
In the U.S.
Available Dosage Forms:
Therapeutic Class: Benign Prostatic Hypertrophy Agent
Pharmacologic Class: 5-Alpha Reductase Inhibitor
Note: Women of childbearing potential should not use or handle dutasteride capsules. Dutasteride can cause birth defects in male fetuses.
Dutasteride is used alone or in combination with tamsulosin (Flomax®) to treat men who have symptoms of an enlarged prostate gland, which is also known as benign prostatic hyperplasia (BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. As the prostate gland enlarges, certain muscles in the gland may become tight and get in the way of the tube that drains urine from the bladder. This can cause problems with urinating, such as a need to urinate often, a weak stream when urinating, or a feeling of not being able to empty the bladder completely.
Dutasteride blocks the action of an enzyme called 5-alpha-reductase. This enzyme changes testosterone to another hormone that causes the prostate to grow. As a result, the size of the prostate is decreased. The effect of dutasteride lasts only as long as the medicine is taken. If it is stopped, the prostate begins to grow again.
dutasteride is available only with your doctor's prescription.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, dutasteride is used in certain patients with the following medical conditions:
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dutasteride, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to dutasteride or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Dutasteride is not indicated for use in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dutasteride in the elderly.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | X | Studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dutasteride, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using dutasteride with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of dutasteride. Make sure you tell your doctor if you have any other medical problems, especially:
Take dutasteride exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
You may take dutasteride with or without food.
Swallow the capsule whole. Do not crush, chew, or open it. The contents of the capsule may irritate your lips, mouth, or throat.
dutasteride comes with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.
The dose of dutasteride will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dutasteride. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of dutasteride, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check you at regular visits to make sure that dutasteride is working properly and to check for any unwanted effects that may be caused by dutasteride.
Women and children should not use dutasteride. Pregnant women or women who may become pregnant should not handle or touch the capsules. Dutasteride can be absorbed through the skin and can cause birth defects in male fetuses. If a pregnant woman does come in contact with dutasteride, the affected area should be washed right away with soap and water, especially if the capsule is broken.
Men who have taken dutasteride should not donate blood until 6 months have passed since the last dose. Dutasteride can remain in your blood for a long time and be passed on to a pregnant woman who receives a blood transfusion.
dutasteride may increase your risk of developing high-grade prostate cancer. Tell your doctor if you have concerns about this risk.
dutasteride may affect the results of the prostate specific antigen (PSA) test, which may be used to detect prostate cancer. Make sure you tell all of your doctors that you are using dutasteride.
dutasteride does not usually affect normal sexual abilities for most men. You may notice that you ejaculate less fluid when you have sex.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: dutasteride side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Prostall may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Prostall in the following countries:
International Drug Name Search
Cesamet is a brand name of nabilone, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Cesamet available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cesamet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Cesamet.
Amsati may be available in the countries listed below.
Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Amsati in the following countries:
International Drug Name Search
Eryhexal may be available in the countries listed below.
Erythromycin is reported as an ingredient of Eryhexal in the following countries:
Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Eryhexal in the following countries:
Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Eryhexal in the following countries:
International Drug Name Search
Bioquinavir may be available in the countries listed below.
Saquinavir is reported as an ingredient of Bioquinavir in the following countries:
International Drug Name Search
Néomycine Hydrocortisone may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Néomycine Hydrocortisone in the following countries:
Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Néomycine Hydrocortisone in the following countries:
Tetracaine hydrochloride (a derivative of Tetracaine) is reported as an ingredient of Néomycine Hydrocortisone in the following countries:
International Drug Name Search
Doloran may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Doloran in the following countries:
International Drug Name Search
Hibital may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Hibital in the following countries:
Isopropyl Alcohol is reported as an ingredient of Hibital in the following countries:
International Drug Name Search
Alugastrin may be available in the countries listed below.
Carbaldrate is reported as an ingredient of Alugastrin in the following countries:
International Drug Name Search
